SCHEMBL5404930

SCHEMBL5404930

Cc1cc(Cn2c[c]c3ccccc32)c2ccccc2n1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
NCF1 P14598 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.37
RAB9A P51151 1/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
CYP2C19 P33261 1/20 0.36
MMP13 P45452 1/20 0.36
ADAM17 P78536 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
TNF P01375 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5405524 0.77 CYP1A2 (0.46) CYP1A2NCF1
SCHEMBL3970337 0.75 NCF1 (0.53) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL5404925 0.75 CYP1A2 (0.44) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL3969617 0.72 CYP1A2 (0.41) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL4048580 0.72 CYP1A2 (0.41) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL3969618 0.72 NCF1 (0.49) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL694560 0.70 TNF (0.44) SMN1; SMN2KDM4ECYP11B1CYP11B2TNF
SCHEMBL5898542 0.70 CYP1A2 (0.60) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL6985541 0.70 CYP1A2 (0.60) CYP1A2NCF1SMN1; SMN2HTTKDM4E
SCHEMBL3970334 0.69 CYP1A2 (0.44) CYP1A2NCF1SMN1; SMN2HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7294624-B2 Osteoporosis; antiarthritic agents BRISTOL MYERS SQUIBB COMPANY (US) 2007-11-13 US disclosed